Modus Outcomes brings the patient voice to clinical research. Our work, grounded in the patient experience, allows us to design meaningful outcome measures to optimize decision-making about the development, commercialization and use of medical products.
In partnership with you, we design bespoke PCO strategies to accumulate evidence to successfully meet your clinical development goals and beyond. Our recommendations are customized to reduce risk and optimize decision making.
We deliver fit-for-purpose patient-centered outcome measures to detect meaningful and interpretable treatment benefit. Our expertise spans all stages of instrument development.
We ensure that patient-centered outcomes evidence generation supports your product strategy, so you can fully leverage the results in your regulatory and market access plans.
We act as catalysts to foster a patient-centered outcome culture across functional teams in your company. Our workshops are jargon-free and tailored to the audience. We are also excited to provide advanced PCO workshops on mixed methods research, measurement and statistics.
Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA) are rare neurodegenerative diseases, which cause progressive, proximal-to-distal muscular weakness leading to loss of ambulation and motor function. Worldwide, they are the leading cause of neuromuscular disorders affecting children, which has led to an active research field to discover new DMD and SMA therapies. In February […]
CIC, 1 Broadway, 14th Floor
Cambridge, MA 02142
USA
4th Floor St. James House, St. James Square, Cheltenham, England, GL50 3PR
UK
Wojo Grand Hôtel-Dieu
4 place Amédée Bonnet
69002 Lyon
FRANCE
